Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status

(2021) Yonggang Zhou et al.   JOURNAL OF AUTOIMMUNITY

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD

(2021) Yunjiao Zhou et al.   Cell Reports

High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages

(2021) Willianne Hoepel et al.   Science Translational Medicine

Cross-reactive antibody immunity against SARS-CoV-2 in children and adults

(2021) Elizabeth Fraley et al.   Cellular & Molecular Immunology

SARS-CoV-2 variants, spike mutations and immune escape

(2021) William T. Harvey et al.   NATURE REVIEWS MICROBIOLOGY

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

(2021) Meng Yuan et al.   SCIENCE

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?

(2021) Ivana Lazarevic et al.   Viruses-Basel

Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients

(2021) Andrew D. Moura et al.   Scientific Reports

Human plasma IgG1 repertoires are simple, unique, and dynamic

(2021) Albert Bondt et al.   Cell Systems

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination

(2021) Tom G. Caniels et al.   Science Advances

Saliva SARS-CoV-2 Antibody Prevalence in Children

(2021) Maya W. Keuning et al.   Microbiology Spectrum

Highly active engineered IgG3 antibodies against SARS-CoV-2

(2021) Somanath Kallolimath et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

(2021) Marloes Grobben et al.   eLife

Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses

(2021) Victor Yin et al.   ACS Central Science

High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19

(2021) Winston A. Haynes et al.   Communications Biology

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

(2020) Li Guo et al.   CLINICAL INFECTIOUS DISEASES

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

(2020) Juanjuan Zhao et al.   CLINICAL INFECTIOUS DISEASES

Human neutralizing antibodies elicited by SARS-CoV-2 infection

(2020) Bin Ju et al.   NATURE

Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease

(2020) Christoph Schultheiß et al.   IMMUNITY

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

(2020) Fabian Schmidt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

(2020) Philip J. M. Brouwer et al.   SCIENCE

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections

(2020) Huibin Lv et al.   Cell Reports

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

(2020) Guillaume Beaudoin-Bussières et al.   mBio

Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients

(2020) Xuefeng Niu et al.   Frontiers in Immunology

Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay

(2020) Joachim Mariën et al.   JOURNAL OF VIROLOGICAL METHODS

Dissecting ribosomal particles throughout the kingdoms of life using advanced hybrid mass spectrometry methods

(2018) Michiel van de Waterbeemd et al.   Nature Communications

The promise and challenge of high-throughput sequencing of the antibody repertoire

(2014) George Georgiou et al.   NATURE BIOTECHNOLOGY